Indeed, it was shown that SARS-CoV-2 infection after spike-based vaccination allows the development of T-cells specific against other SARS-CoV-2 antigens [36], and a rapid and extensive recall of spike-specific CD4 and CD8 occurs early after Delta or Omicron breakthrough infection [37]. The gene discussed is CD8A; the disease is infection.